Insights into innate immune cell evasion by Chlamydia trachomatis
Chlamydia trachomatis , is a kind of obligate intracellular pathogen. The removal of C. trachomatis relies primarily on specific cellular immunity. It is currently considered that CD4 + Th1 cytokine responses are the major protective immunity against C. trachomatis infection and reinfection rather t...
Saved in:
Published in | Frontiers in immunology Vol. 15; p. 1289644 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Chlamydia trachomatis
, is a kind of obligate intracellular pathogen. The removal of
C. trachomatis
relies primarily on specific cellular immunity. It is currently considered that CD4
+
Th1 cytokine responses are the major protective immunity against
C. trachomatis
infection and reinfection rather than CD8
+
T cells. The non-specific immunity (innate immunity) also plays an important role in the infection process. To survive inside the cells, the first process that
C. trachomatis
faces is the innate immune response. As the “sentry” of the body, mast cells attempt to engulf and remove
C. trachomatis
. Dendritic cells present antigen of
C. trachomatis
to the “commanders” (T cells) through MHC-I and MHC-II. IFN-γ produced by activated T cells and natural killer cells (NK) further activates macrophages. They form the body’s “combat troops” and produce immunity against
C. trachomatis
in the tissues and blood. In addition, the role of eosinophils, basophils, innate lymphoid cells (ILCs), natural killer T (NKT) cells, γδT cells and B-1 cells should not be underestimated in the infection of
C. trachomatis
. The protective role of innate immunity is insufficient, and sexually transmitted diseases (STDs) caused by
C. trachomatis
infections tend to be insidious and recalcitrant. As a consequence,
C. trachomatis
has developed a unique evasion mechanism that triggers inflammatory immunopathology and acts as a bridge to protective to pathological adaptive immunity. This review focuses on the recent advances in how
C. trachomatis
evades various innate immune cells, which contributes to vaccine development and our understanding of the pathophysiologic consequences of
C. trachomatis
infection. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 Roshan Pais, Rajiv Gandhi University of Health Sciences, India Edited by: Lei Song, First Affiliated Hospital of Jilin University, China Reviewed by: Karthika Rajeeve, Rajiv Gandhi Centre for Biotechnology, India |
ISSN: | 1664-3224 1664-3224 |
DOI: | 10.3389/fimmu.2024.1289644 |